戻る Agenda
Disruptive Transformation in Safety Organizations
Session Chair(s)
William Gregory, PHD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
Pharmacovigilance (PV) transformation is top-of-mind for safety leaders. Internal and external stakeholders demand fresh thinking regarding operating models and capabilities for PV organizations. Forward-thinking leaders are pulling on multiple strategic levers, from bringing in new ways of thinking to acquiring a different type of talent to implementing game-changing technologies. The pharma companies that will be the most competitive in the future are the ones that are able to quickly transform.
Learning Objective : Discuss how to transform their PV organizations into more strategic and elevated operating models; Describe how to adapt agile methods and approaches to the safety-critical, compliance-driven environment of healthcare;Identify how to apply the agile approach to areas other than software development.
Speaker(s)
Workload! What Can We Pull Out of Our Pharmacovigilance Toolkit to Spell Success in 2030?
William Gregory, PHD
Pfizer Inc, United States
Senior Director, Safety and Risk Management
The Secret Ingredients to Reinventing Drug Safety Organizations
Kemi Yusuf, MBA, PMP
AbbVie, United States
Vice President, Safety Operations
Agility and Safety: Are They Compatible?
Alan Hochberg
Genentech, A Member of the Roche Group, United States
Principal Scientific Enablement Director, Scientific Enablement and Processes